NPRL2 and cancer: Our group along with others in different cancers previously reported that NPRL2 enhances sensitivity to chemotherapy and overcomes drug resistance (Ueda et al., 2006; Jayachandran et al., 2010; Liu et al., 2015a; Liu et al., 2015c; Liu et al., 2019).